Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sierra Oncology Inc (SRRA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sierra Oncology's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Sierra Oncology historical data, for real-time data please try another search
54.99 +0.00    +0.00%
30/06 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 54.98 - 55.17
Sierra Oncology 54.99 +0.00 +0.00%

SRRA Recent Sentiments

 
This page contains information on users’ sentiments for the Sierra Oncology Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jun 03, 2022 Haleem Sadiq   54.91 Jun 24, 2022 @ 54.91 0.00%
Apr 14, 2022 Javier Bartres   54.76 May 06, 2022 @ 54.52 -0.44%
Apr 13, 2022 Israel Veleces   54.48 May 06, 2022 @ 54.52 -0.07%
Jan 26, 2022 Juan Gamisans   28.64 Jan 27, 2022 @ 27.34 +4.54%
Jan 26, 2022 Robbert Kuipers   26.34 Feb 18, 2022 @ 31.71 +20.39%
Jan 26, 2022 Robbert Kuipers   26.24 Jan 26, 2022 @ 26.24 0.00%
Jan 25, 2022 Terence Reeves   22.66 Feb 18, 2022 @ 31.71 +39.94%
Jan 25, 2022 bhuvnesh sharma   24.94 Feb 03, 2022 @ 30.16 -20.93%
Jan 25, 2022 Avishay Buchbut   25.04 Feb 18, 2022 @ 31.71 +26.64%
Jan 25, 2022 José dos Santos   24.91 Jan 31, 2022 @ 27.22 -9.27%
Jan 25, 2022 Juan Gamisans   24.80 Jan 25, 2022 @ 22.45 +9.48%
Jan 25, 2022 FILIPPO AUGUSTO...   21.93 Feb 18, 2022 @ 31.71 +44.60%
Jan 25, 2022 Deepak Rao   22.30 Feb 18, 2022 @ 31.71 -42.20%
Jan 25, 2022 国臻 郑   22.16 Jan 31, 2022 @ 27.22 -22.83%
Jan 25, 2022 Fa Aa   23.01 Feb 18, 2022 @ 31.71 +37.81%
Jan 25, 2022 Nelly Canales   23.09 Feb 18, 2022 @ 31.71 +37.33%
Aug 09, 2021 Adrian Kurti   19.25 Sep 03, 2021 @ 19.19 -0.31%
Jul 08, 2021 Sajith Sreedharan   19.52 Jul 30, 2021 @ 19.00 -2.66%
Jul 07, 2021 Israel Veleces   19.52 Jul 12, 2021 @ 21.28 -9.02%
Apr 12, 2021 Kurt Spach   17.58 May 07, 2021 @ 19.17 +9.04%
Dec 17, 2020 Jay Nam   15.26 Jan 08, 2021 @ 15.85 -3.87%
Dec 10, 2020 Adrian Kurti   15.09 Jan 01, 2021 @ 16.03 +6.23%
Dec 01, 2020 Manu Manu   13.94 Dec 25, 2020 @ 16.04 +15.06%
Nov 13, 2020 Mohamed Ait Bassou   14.37 Dec 04, 2020 @ 13.78 -4.11%
Nov 03, 2020 Jon Jay   14.20 Nov 27, 2020 @ 14.20 -0.04%
Sep 01, 2020 Andreas Schatz   11.60 Sep 25, 2020 @ 10.75 -7.33%
Jun 22, 2020 behnam sadeghikhoshde   14.23 Jul 17, 2020 @ 13.20 -7.27%
May 15, 2020 Manu Manu   11.36 Jun 05, 2020 @ 14.03 +23.50%
Feb 11, 2020 Edwin Cruz   14.73 Mar 06, 2020 @ 12.85 -12.76%
Jan 25, 2020 Ilan Dahan   12.75 Jan 30, 2020 @ 11.92 -6.51%
Jan 23, 2020 Oscar Chong   13.45 Feb 14, 2020 @ 15.48 -15.09%
Jan 23, 2020 Leonid Olimpiev   13.12 Feb 02, 2020 @ 12.11 +7.70%
Jan 23, 2020 kaushik bhatt   13.12 Feb 14, 2020 @ 15.48 +17.99%
Jan 23, 2020 Steve Sterriker   12.90 Feb 14, 2020 @ 15.48 +20.00%
Jan 23, 2020 CARLA FERNANDES   13.29 Feb 14, 2020 @ 15.48 +16.48%
Jan 23, 2020 Wassim Hayder   13.50 Feb 14, 2020 @ 15.48 +14.67%
Jan 23, 2020 Andreas Schatz   12.95 Feb 14, 2020 @ 15.48 +19.54%
Jan 23, 2020 karen gevorgyan   13.75 Feb 14, 2020 @ 15.48 -12.58%
Jan 23, 2020 Kyle Bandura   13.75 Feb 14, 2020 @ 15.48 +12.58%
Jan 23, 2020 davide garulli   13.75 Feb 04, 2020 @ 0.02 +99.84%
Jan 23, 2020 davide garulli   0.35 Jan 23, 2020 @ 13.75 +3854.56%
Jan 13, 2020 PAPPAERT ANDRE   0.38 Feb 07, 2020 @ 12.68 +3236.84%
Jan 06, 2020 acemi borsacı   0.39 Jan 31, 2020 @ 12.11 +3005.13%
Dec 30, 2019 Are Bank   0.33 Jan 24, 2020 @ 12.75 +3763.64%
Dec 24, 2019 Jamie Neadow   0.34 Dec 26, 2019 @ 0.34 0.00%
Dec 18, 2019 Jamie Neadow   0.35 Dec 19, 2019 @ 0.33 -5.71%
Dec 18, 2019 Jamie Neadow   0.35 Dec 18, 2019 @ 0.35 0.00%
Dec 11, 2019 Matthew Peterson   0.39 Jan 03, 2020 @ 0.40 -2.05%
Dec 10, 2019 Gianni Amoruso   0.39 Jan 03, 2020 @ 0.40 +2.05%
Dec 09, 2019 Angelo Sani   0.44 Jan 03, 2020 @ 0.40 +9.55%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRRA Comments

Write your thoughts about Sierra Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Paul Lavin
Paul Lavin Jan 26, 2022 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now at $28.64, cant short they turned off shorting, over valued, this will come crashing down soon
Ishtiaq Bokhari
Ishtiaq Bokhari Jan 25, 2022 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
let see
Carlos Andres
Carlos Andres Jan 25, 2022 9:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow
Serge Landry
Serge Landry Feb 25, 2020 10:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tabarnack!
Serge Landry
Serge Landry Jan 23, 2020 6:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Read the news!
Tibor Horváth
Tibor Horváth Jan 23, 2020 11:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happening???
Fisum Keberabe
Fisum Keberabe Jan 23, 2020 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats happening ?
Matthew Peterson
Matthew Peterson Dec 11, 2019 2:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol
Jeremy Swainston
Jeremy Swainston Jun 06, 2019 10:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This company is low key going bankrupt..They need help bad and stock will be at .19 this is a shady company with great news at hand, all there funds are fake...There robbing shares
Jeremy Swainston
Jeremy Swainston Jun 04, 2019 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So let me get this straight, this wierd failing company has great p2 results, great earnings, money, companies looking good as far as the public sees, then the stock skyrockets down to .70 from 1.20 from great news. I swear u stock hackers are gonna get beat down one of theses days
Paul Lavin
Paul Lavin Jun 04, 2019 7:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now look
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email